Underdiagnosis: A limitation to the follow-up of alpha 1 antitrypsin deficiency in the patient with COPD
DOI:
https://doi.org/10.56102/afmo.2021.138Keywords:
Pulmonary Emphysema, Pulmonary Disease, Chronic Obstructive, alpha 1-Antitrypsin Deficiency, Epidemiologic StudiesAbstract
Alpha-1 antitrypsin (AAT) deficiency (AATD) is a rare autosomal codominant hereditary disorder that mainly affects the lungs and liver1. The only Brazilian study reporting the prevalence of A1ATD estimates that 2.8% of COPD patients have this deficiency.2 The objective of this case report is to demonstrate the need to investigate A1ATD in view of the characterization by clinical, functional and radiological criteria, avoiding underdiagnosis and deterioration of the clinical condition due to limited follow-up.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Rafaela Feijó Henriques de Araújo, Marcus Vinícius Guerra Canto , Ana Maria Ataíde de Godoy Pedrosa , Bruna Rocha Menelau de Souza, Alina Farias França de Oliveira

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Esta licença permite que outros distribuam, remixem, adaptem e desenvolvam seu trabalho, mesmo comercialmente, desde que creditem a revista pela criação original.